Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Cosmos Pharmaceutical Corp
OTC:CSMYF
Cosmos Pharmaceutical Corp
OTC:CSMYF
Price:
48.271
USD
-21.37%
Market Closed
Market Cap:
$3.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
CSMYF Price Forecast
Based on 13 analysts
Based on 13 analysts
+18% Upside
from
$48.271
today
Cosmos Pharmaceutical Corp (CSMYF)’s 12-month stock price forecast through December 2026 has a consensus target of $56.898, implying 18% upside. The forecast is based on price targets from 13 Wall Street analysts.
CSMYF Analyst Rating
No ratings yet
No ratings yet
Cosmos Pharmaceutical Corp Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CSMYF's stock price target?
Price Target
56.898
USD
56.898
USD
According to Wall Street analysts, the average 1-year price target for CSMYF is 56.898 USD with a low forecast of 51.71 USD and a high forecast of 80.235 USD.
What is the Revenue forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
9%
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
15%
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 1 year is 15%.
What is the Pre-Tax Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
7%
7%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
5%
5%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.
